Resumen de Investigación
Analyzed using Evidence Intelligence™

Intermittent fasting improves glycemic control in insulin-treated type 2 diabetes

Última actualización 4 de septiembre de 2026

Key finding

HbA1c decreased by 7.3 ± 12.0 mmol/mol in the IF group compared to an increase of 0.1 ± 6.1 mmol/mol in the control group.

The INTERFAST-2 study evaluated the effects of intermittent fasting on individuals with insulin-treated type 2 diabetes, finding significant improvements in glycemic control and weight loss.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Extended (5–20+ y)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

The INTERFAST-2 study evaluated the effects of intermittent fasting on individuals with insulin-treated type 2 diabetes, finding significant improvements in glycemic control and weight loss.

Clinical relevance

These findings suggest that intermittent fasting could be a beneficial dietary strategy for managing type 2 diabetes, potentially leading to better glycemic control and reduced medication needs. This approach may help patients achieve weight loss and improve their overall health, which is crucial in diabetes management.

Keep in mind

Limited sample size may affect generalizability. Short duration of the study may not capture long-term effects. Lack of diversity in the participant population.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Anna O, Norbert JT, Peter NP, et al. Intermittent fasting in subjects with insulin-treated type 2 diabetes mellitus (INTERFAST-2). Diabetes Care. 2023;46(2):463-468. doi:10.2337/dc22-1622

Efectos Principales

HbA1c decreased by 7.3 ± 12.0 mmol/mol in the IF group (p=0.012).

Weight decreased by 4.77 ± 4.99 kg in the IF group (p=0.001).

Total daily insulin dose reduced by 9 ± 10 IU in the IF group (p=0.008).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Control Group Usual Activity, Intermittent Fasting (IF) and HbA1c, Body fat mass, Change in self-reported perceived health status, and 5 more.

Primary intervention

Control Group Usual Activity

Primary outcomes

  • HbA1c
  • Body fat mass
  • Change in self-reported perceived health status

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

9
Evidence pairs
9
Relationships
6
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

6

Related topics

9

Evidence pairs

2131

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 9 evidence relationships
  • Includes primary outcome data
  • Linked to 6 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Tema de evidencia

Dietary Patterns

matched_intervention_and_outcome

Evidencia relacionada

Tema de evidencia

CGM Time in Range

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

HbA1c

Control Group Usual Activity → HbA1c

Control Group Usual Activity → HbA1c

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 3 studies
ImpactScore™
50
Neutral
ConsistencyScore™
67
generally_consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence Tracker

Body fat mass

Intermittent Fasting (IF) → Body fat mass

Intermittent Fasting (IF) → Body fat mass

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Change in self-reported perceived health status

Intermittent Fasting (IF) → Change in self-reported perceived health status

Intermittent Fasting (IF) → Change in self-reported perceived health status

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Composite endpoint achievement

Intermittent Fasting (IF) → Composite endpoint achievement

Intermittent Fasting (IF) → Composite endpoint achievement

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

HbA1c

Intermittent Fasting (IF) → HbA1c

Intermittent Fasting (IF) → HbA1c

Evidence Intelligence™
EvidenceScore™
84
Strong
ImpactScore™
100
Very Positive
ConsistencyScore™
100
consistent
Estudios de apoyo: Basado en 5 estudios
Add to Evidence Tracker

Time above range

Intermittent Fasting (IF) → Time above range

Intermittent Fasting (IF) → Time above range

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Time in range

Intermittent Fasting (IF) → Time in range

Intermittent Fasting (IF) → Time in range

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Total daily insulin dose

Intermittent Fasting (IF) → Total daily insulin dose

Intermittent Fasting (IF) → Total daily insulin dose

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
75
Positive
ConsistencyScore™
100
consistent
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Weight change

Intermittent Fasting (IF) → Weight change

Intermittent Fasting (IF) → Weight change

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 3 studies
ImpactScore™
100
Very Positive
ConsistencyScore™
100
consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • 8 participants in the IF group achieved the composite end point (p=0.001).
  • Fat mass decreased by 3.5 ± 3.3 kg in the IF group (p=0.001).
  • Mean time in range improved to 68.0 ± 20.2% in the IF group.
who this applies

A quién se aplica

  • Adults with insulin-treated type 2 diabetes.
  • Individuals seeking alternative dietary strategies for diabetes management.
keep in mind

Tener en Cuenta

  • Results may not apply to non-insulin-treated diabetes patients.
  • Further research is needed to confirm long-term effects.
  • Individual responses to intermittent fasting can vary.
between the lines

Entre Líneas

  • Limited sample size may affect generalizability.
  • Short duration of the study may not capture long-term effects.
  • Lack of diversity in the participant population.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Intermittent Fasting (IF) and HbA1c, Control Group Usual Activity and HbA1c.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Intermittent Fasting (IF) lower HbA1c?

Strong Evidence

Intermittent Fasting (IF) appears to lower HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Strong | EvidenceScore™ 83.8 | strong positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Intermittent Fasting (IF) improve weight change?

Strong Evidence

Intermittent Fasting (IF) appears to improve weight change.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Weight change

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Control Group Usual Activity lower HbA1c?

Strong Evidence

Current evidence does not show a clear benefit of Control Group Usual Activity for HbA1c.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | neutral | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Intermittent Fasting (IF) improve total daily insulin dose?

Moderate Evidence

Intermittent Fasting (IF) may improve total daily insulin dose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Total daily insulin dose

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.